*Diabetes Mellitus, Type 2

Ferguson, L. D., Molenberghs, G., Verbeke, G., Rahimi, K., Rao, S., McInnes, I. B., et al. (2024). Gout and incidence of 12 cardiovascular diseases: a case-control study including 152 663 individuals with gout and 709 981 matched controls. Lancet Rheumatol, 6, e156-e167. http://doi.org/10.1016/s2665-9913(23)00338-7
Tyrer, F., Chudasama, Y. V., Lambert, P. C., & Rutherford, M. J. (2023). Flexible parametric methods for calculating life expectancy in small populations. Popul Health Metr, 21, 13. http://doi.org/10.1186/s12963-023-00313-x
Yu, D., Huang, X., Mamas, M. A., & Wilkie, R. (2023). Persistent high prevalence of modifiable cardiovascular risk factors among patients with osteoarthritis in the UK in 1992-2017. Rmd Open, 9. http://doi.org/10.1136/rmdopen-2023-003298
Aoki, Y., Cabrera, C. S., Ouwens, M., Bamberg, K., Nyström, J., Raz, I., et al. (2022). Bilirubin levels and kidney function decline: An analysis of clinical trial and real world data. Plos One, 17, e0269970. http://doi.org/10.1371/journal.pone.0269970